Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U3YC
|
||||
| Former ID |
DNC013632
|
||||
| Drug Name |
LY-2318912
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528802] | ||
| Formula |
C12H12IN9O2
|
||||
| Canonical SMILES |
CN(C)C(=O)N1C(=NN=N1)CNC(=O)C2=CC(=C(C=C2)N=[N+]=[N-])I
|
||||
| InChI |
1S/C12H12IN9O2/c1-21(2)12(24)22-10(17-19-20-22)6-15-11(23)7-3-4-9(16-18-14)8(13)5-7/h3-5H,6H2,1-2H3,(H,15,23)
|
||||
| InChIKey |
QJNXEOBTVAWQME-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [528802] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.